Perimenopause and body odour: why it changes and what is actually happening
Perimenopause changes body odour because falling estrogen increases apocrine gland output, raising the concentration of odour precursors available to skin bacteria. Staphylococcus hominis converts those precursors into thioalcohol compounds through the cysteine-thiol lyase (C-T lyase) enzyme pathway. At the same time, age-related lipid peroxidation activates the 2-nonenal pathway. Three mechanisms are operating at once, and conventional deodorant was calibrated for none of them.
How perimenopause alters body odour
Most people expect perimenopause to bring hot flashes and irregular cycles. Fewer expect it to change the way their body smells. For a significant number of people moving through this hormonal transition, the shift in body odour is among the more disorienting experiences: more intense, more persistent, qualitatively different from before, and resistant to products that worked reliably for years.
This is a biology problem. Perimenopause reorganises the hormonal signals that govern sweat gland behaviour, bacterial enzyme activity, and the lipid chemistry of the skin surface. Each of those changes produces odour through a distinct mechanism. Understanding each one precisely is the only basis for addressing it properly.
In plain terms Why does perimenopause change how I smell?
Your hormones act like volume controls for your sweat glands. During perimenopause, estrogen levels drop, and that reduces its dampening effect on apocrine glands, the ones that produce odour-causing sweat. The result is more sweat, richer in the compounds that bacteria convert into the molecules responsible for body odour. Your deodorant was not designed for this new volume level.
Apocrine glands and hormonal control
Two types of sweat glands are relevant to body odour. Eccrine glands are distributed across the entire body surface and produce a dilute, predominantly water-and-salt secretion for thermoregulation. Eccrine sweat has minimal direct odour contribution at the point of release.
Apocrine glands are the ones responsible for axillary odour. They are concentrated in the armpits, groin, areola, and scalp. Their secretion differs fundamentally from eccrine output: viscous, protein-rich, lipid-laden, and dense with androgen-derived steroid precursors. Fresh apocrine secretion is odourless at release. Bacterial processing is what generates the volatile compounds responsible for the characteristic smell.
Apocrine glands carry receptors for both androgens and estrogens.[1] Androgens stimulate apocrine activity and increase secretion volume. Estrogen, at normal premenopausal levels, is thought to partially suppress apocrine output, acting as a counterbalance to androgen drive. As estrogen declines, this counterbalance is lost.
The cysteine-thiol lyase pathway
The specific chemistry behind axillary odour is now well characterised. The dominant odorant compound in human axillary secretion is 3-methyl-3-sulfanylhexan-1-ol, abbreviated 3M3SH. It is a thioalcohol detectable at extremely low concentrations, reported in the low parts-per-trillion range. It is produced by bacterial enzymatic action on precursor molecules secreted by the apocrine gland. The enzyme responsible is a cysteine-thiol lyase (C-T lyase) encoded by the PatB gene, expressed by Staphylococcus hominis.[2][4]
The rate of thioalcohol production is substrate-limited. When apocrine secretion volume increases as estrogen suppression falls, more precursor reaches the bacterial community. The C-T lyase reaction runs at a higher rate. More 3M3SH is released per unit time. The result is a direct, mechanistically grounded link between estrogen decline and increased axillary odour intensity.
In plain terms What is actually producing the smell?
Your apocrine glands release a fluid that is odourless on its own. Bacteria living on your skin consume it and produce a sulfur-containing compound called 3M3SH. That compound is what you actually smell. During perimenopause, your glands release more fluid, so the bacteria have more to work with, and they produce more 3M3SH. The enzyme they use is called cysteine-thiol lyase (C-T lyase).
The 2-nonenal pathway
Perimenopause coincides in timing with the activation of a second, independent odour pathway: the 2-nonenal pathway. 2-Nonenal is an unsaturated aldehyde produced through oxidative degradation of omega-7 fatty acids on the skin surface.[3] The reaction is driven by lipid peroxides through a purely chemical oxidative process, and it proceeds at a rate that increases with age.
2-Nonenal has a distinctive character: greasy and grassy. When both pathways are active simultaneously, the result is a composite odour profile that is both more intense than before and qualitatively unlike anything the person has experienced from their own body previously.
In plain terms Why does my body odour smell different now, not just stronger?
There are two separate processes happening at the same time. The first produces a sulfury, sharp odour from your apocrine glands. The second produces a different, waxy, slightly grassy smell from fats on your skin surface breaking down through oxidation. These two processes have always existed, but in perimenopause both become more active at the same time. The combination produces an odour character you have not experienced before because both channels were never simultaneously at this volume.
Perimenopausal body odour involves two pathways operating simultaneously. The thioalcohol pathway requires enzyme inhibition that conventional deodorants do not carry. The 2-nonenal pathway requires antioxidant and aldehyde-scavenging chemistry that no antimicrobial product addresses. The VCS covers both.
At the underarm: The Bio-Volatile Inhibitor Endurance Concentrate carries the C-T lyase inhibitor that targets the thioalcohol enzyme directly, alongside antioxidant and aldehyde-scavenging chemistry for the nonenal pathway. This is the primary underarm product for the perimenopausal odour profile.
During the shower: The Bio-Clear: Poly Acid Daily Wash suppresses both pathways during the wash itself: C-T lyase inhibition for thioalcohol, and aldehyde-reactive chemistry that lifts and deactivates nonenal from the skin's lipid layer.
Across the full body: The BVI Lamellar Barrier Primer sustains C-T lyase inhibition, antioxidant protection against lipid peroxidation, carbonyl scavenging for nonenal, and molecular encapsulation across the chest, back, and torso throughout the day. 2-Nonenal is whole-body by nature, and the Primer is the only product that addresses it beyond the underarm.
If the deodorant has gradually stopped working: The Bio-Reset: Poly Acid Resurfacing Wash, used in place of the daily wash two to three times per week, dismantles biofilm and clears the follicular reservoir, restoring product access to the skin. It also carries the C-T lyase inhibitor during the reset.
Why the Bio-Volatile Inhibitor Concentrate is not suited here: The paste does not carry the C-T lyase inhibitor the thioalcohol pathway requires. At the detection thresholds involved, bacterial reduction alone cannot bring thioalcohol output below what the nose detects.
The full pathway guide covers every pathway and structural challenge in detail.
Frequently asked questions
Does perimenopause cause stronger body odour?
Yes. Estrogen decline reduces apocrine gland suppression, increasing the volume and odour-precursor concentration of apocrine secretion. Bacteria convert that secretion into thioalcohol compounds at higher rates when more substrate is available.
What is the main cause of perimenopausal body odour?
Increased apocrine secretion driven by falling estrogen levels. Bacteria express cysteine-thiol lyase (C-T lyase), an enzyme that converts apocrine precursors into 3-methyl-3-sulfanylhexan-1-ol (3M3SH), the main thioalcohol responsible for axillary odour.
Why does armpit odour during perimenopause have a different character, not just greater intensity?
The qualitative change is due to the 2-nonenal pathway activating concurrently with the apocrine changes. 2-Nonenal, produced through age-related lipid peroxidation of skin surface fatty acids, has a greasy, grassy character distinct from the sulfurous quality of thioalcohol odour.
Does regular deodorant work for hormonal body odour?
Conventional deodorant is calibrated for a pre-perimenopausal odour profile. At perimenopausal apocrine output levels, the antibacterial and odour-masking components are under-dosed relative to the substrate volume they are now facing. A formulation designed to address multiple odour pathways simultaneously is required.
Can hormone replacement therapy (HRT) reduce perimenopausal body odour?
HRT restores estrogen levels, which may partially restore the suppressive effect on apocrine gland output. Whether this is sufficient to return body odour to pre-perimenopausal levels depends on the individual, the HRT regimen, and whether the 2-nonenal pathway is also active. HRT is a medical decision that should be discussed with a physician.
Is perimenopausal body odour permanent?
The hormonal changes driving increased apocrine output are part of a transition that stabilises post-menopause. Whether the odour intensity remains, reduces, or changes character after menopause varies between individuals. The 2-nonenal pathway, which is age-related rather than hormone-related, tends to continue independently of menopausal status.
This article is for educational purposes only and does not constitute medical advice. If you have concerns about body odour, skin conditions, or any health issue, consult a qualified healthcare professional. SD Labs provides science-backed information to help you understand your body, not to replace professional medical guidance.
Scientific references
- Beier K, Ginez I, Schaller H. Localization of steroid hormone receptors in the apocrine sweat glands of the human axilla. Histochem Cell Biol. 2005;123(1):61-65. doi:10.1007/s00418-004-0736-3
- Bawdon D, Cox DS, Ashford D, James AG, Thomas GH. Identification of axillary Staphylococcus sp. involved in the production of the malodorous thioalcohol 3-methyl-3-sulfanylhexan-1-ol. FEMS Microbiol Lett. 2015;362(16):fnv111. doi:10.1093/femsle/fnv111
- Haze S, Gozu Y, Nakamura S, Kohno Y, Sawano K, Ohta H, Yamazaki K. 2-Nonenal newly found in human body odour tends to increase with aging. J Invest Dermatol. 2001;116(4):520-524. doi:10.1046/j.0022-202X.2001.01287.x
- Rudden M, Herman R, Rose M, et al. The molecular basis of thioalcohol production in human body odour. Sci Rep. 2020;10:12500. doi:10.1038/s41598-020-68860-z
2 comments
Yes, but what are we supposed to do about it?
Thanks for including actual science (and appropriate notation/sources)! Very interesting reading and good stuff to know!